Trial Profile
Role of bowel ultrasonography to guide treatment with vedolizumab in patients with Crohn's disease and ulcerative colitis - VedoSono
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Jun 2020
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Therapeutic Use
- Acronyms VedoSono
- Sponsors Takeda
- 26 Jun 2018 New trial record